AstraZeneca’s $1.1 Billion Acquisition of Icosavax

Centerview Partners LLC is serving as exclusive financial advisor to Icosavax and Goodwin is serving as legal counsel. Icosavax, Inc. (Nasdaq: ICVX) announced it has entered…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Sonia Carcano

Author: Sonia Carcano

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here